The Levofloxacin Tablets, cataloged under National Stock Number 6505-01-444-6633, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Major Pharmaceuticals Inc. Government technical data includes 3 specifications, cited from the U.S. Government catalog. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: PG.
| Item Name | Levofloxacin Tablets |
| FSC / FSG | 6505 — Drugs and Biologicals (FSG 65) |
| Manufacturers | Major Pharmaceuticals Inc (CAGE 0SYT3) |
| Parameter | Value |
|---|---|
| NSN | 6505-01-444-6633 |
| Primary Part Number | NDC00904-6351-61 |
| Item Name | Levofloxacin Tablets |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Major Pharmaceuticals Inc |
| Status | ACTIVE |
| Primary Container Content Quantity | 100.0 TABLETS |
| Supplementary Features | 250 MG LEVOFLOXACIN; 100 TABLETS; UNIT DOSE |
| Primary Container Type | BOTTLE |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | PG |
| Part Number | Manufacturer |
|---|---|
| NDC00904-6351-61 | Major Pharmaceuticals Inc (USA) |
| Reference | Meaning |
|---|---|
| NDC00904-6351-61 | 3/1 Design control — primary reference Dr Reddy's Laboratories, Inc. |
| NDC68084-0481-01 | 5/9 Secondary reference Amerisource Health Services, Llc Dba Amerisource Health Packaging |
NSN 6505-01-444-6633 is a Levofloxacin Tablets, manufactured by Major Pharmaceuticals Inc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-444-6633 has 1 manufacturer part number on file: NDC00904-6351-61 (Major Pharmaceuticals Inc).
Key specifications for NDC00904-6351-61: Primary Container Content Quantity: 100.0 TABLETS; Supplementary Features: 250 MG LEVOFLOXACIN; 100 TABLETS; UNIT DOSE; Primary Container Type: BOTTLE; Part Name Assigned by Controlling Agency: LEVOFLOXACIN TABLETS 250MG 100S PG. 3 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.